Traceless Staudinger ligation enabled parallel synthesis of proteolysis targeting chimera linker variants
- PMID: 33406191
- PMCID: PMC7962863
- DOI: 10.1039/d0cc05395c
Traceless Staudinger ligation enabled parallel synthesis of proteolysis targeting chimera linker variants
Abstract
A parallel, one-pot assembly approach to proteolysis targeting chimeras (PROTACs) is demonstrated utilizing activated esters generated in situ, and traceless Staudinger ligation chemistry. The method described allows for rapid structure-activity relationship studies of PROTAC linker variants. Two previously studied systems, cereblon and BRD4 degraders, are examined as test cases for the synthetic method. The two related strategies to assemble PROTAC linker variants discussed can accommodate the chromotographic separations capabilities of labs of many sizes and incorporates commercially available degrader building blocks, thereby easing synthetic entry into PROTAC chemical space.
Conflict of interest statement
Conflicts of interest
There are no conflicts to declare.
Figures




References
-
- Schneider G, Nature Rev. Drug Discov, 2018, 17, 97–113. - PubMed
-
- Jaeger MG and Winter GE, Cell Chem. Biol, 2020, 27, 14–16; - PubMed
- Churcher I, J. Med. Chem, 2018, 61, 444–452; - PubMed
- Tan L and Gray NS, Chin. J. Chem, 2018, 36, 971–977;
- Toure M and Crews CM, Angew. Chem. Int. Ed. Engl, 2016, 55, 1966–1973; - PubMed
- Buetow L and Huang DT, Nat. Rev. Mol Cell. Biol, 2016, 17, 626–642; - PMC - PubMed
- Deshaies RJ, Nat. Chem. Biol, 2015, 11, 634–635. - PubMed
-
- Bondeson DP, Smith BE, Burslem GM, Buhimschi AD, Hines J, Jaime-Figueroa S, Wang J, Hamman BD, Ishchenko A and Crews CM, Cell. Chem. Biol, 2018, 25, 78–87; - PMC - PubMed
- Moon S and Lee BH, Mol. Cell, 2018, 41, 933–942; - PMC - PubMed
- Dang CV, Reddy EP, Shokat KM and Soucek L, Nat. Rev. Cancer, 2017, 17, 502–508; - PMC - PubMed
- Crews CM, Chem. Biol, 2010, 17, 551–555. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources